Back to Search
Start Over
Safety of Lanreotide 120 mg ATG in combination with metformin in patients with progressive advanced well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: the MetNET-2 trial
- Source :
- Annals of Oncology. 27:iv25
- Publication Year :
- 2016
- Publisher :
- Elsevier BV, 2016.
- Subjects :
- medicine.medical_specialty
Lung
business.industry
Hematology
Lanreotide
Gastroenterology
Metformin
Well differentiated
Surgery
chemistry.chemical_compound
medicine.anatomical_structure
Oncology
chemistry
Internal medicine
medicine
In patient
Open label
Prospective cohort study
business
Gastro intestinal
medicine.drug
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 27
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........79ffa74b80ccae8c95c8e2ed00bfb447
- Full Text :
- https://doi.org/10.1093/annonc/mdw333.28